Dr. Vandervest is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3410 Worth St
Ste 250
Dallas, TX 75246Phone+1 214-820-2346Fax+1 215-820-9818
Education & Training
University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 2008 - 2011- University of ColoradoResidency, Internal Medicine, 2005 - 2008
Indiana University School of MedicineClass of 2005
Certifications & Licensure
TX State Medical License 2020 - 2025
CO State Medical License 2008 - 2023- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 9 citationsRecipient risk factors and lung transplant outcomes.Katherine M. Vandervest, Martin R. Zamora
Current Opinion in Organ Transplantation. 2013-10-01 - 74 citationsSprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPARγ in Non–Small Cell Lu...Meredith A. Tennis, Michelle Van Scoyk, Scott V. Freeman, Katherine M. Vandervest, Raphael A. Nemenoff
Molecular Cancer Research. 2010-06-01 - 30 citationsLate-onset Cytomegalovirus (CMV) in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?Kelly E. Schoeppler, Dennis M. Lyu, Todd J. Grazia, Joseph T. Crossno, Katherine M. Vandervest
American Journal of Transplantation. 2013-02-01
Journal Articles
- Recipient Risk Factors and Lung Transplant OutcomesVandervest KM, Zamora MR, Curr Opin Organ Transplant, 10/2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
